Report Highlights
The U.S. market for assistive technologies is projected to grow from $39.5 billion (including eyeglasses and contact lenses) in 2010 to $41.1 billion in 2011 and $55 billion in 2016, a compound annual growth rate (CAGR) of 6% between 2011 and 2016.
SCOPE AND FORMAT
The report focuses on the U.S. market for the various types of devices and products that are on the market or under development to enable disabled and elderly persons to move about, see, hear, speak, dress themselves, and perform many other everyday activities as “normally” as possible. Where practical, market developments on the global level are also addressed, although in less detail than domestic market developments.
In the past few years, BCC has published a number of other reports in related areas, such as prosthetics and orthotics, microelectronic medical implants, drugs for the elderly, as well as anti-aging products. The findings and conclusions of these other reports will be cited in this report, where appropriate, for the sake of completeness. However, it is not the author’s intention to duplicate their coverage and analysis; attention will be focused instead on the following:
- Mobility- and dexterity-enhancing products.
- Products for the vision-, hearing-, and speech-impaired.
- Toileting and incontinence products.
- Medical/personal monitoring products.
- Other products such as environmental controls and daily living aids.
This report does not cover physical therapy and exercise equipment designed for the elderly and disabled. The scope of this report also does not include therapeutic treatments such as surgery that are intended to mitigate or eliminate the underlying causes of a particular disability.
In terms of format, the report is divided into the following major sections:
- Technologies used in disabled and elderly care products
- Conditions and applications addressed
- Product types
- Legal, regulatory, and insurance issues
- Patent and IP issues
- Market size and segmentation
- Market drivers
- Market projections from 2010 through 2016
- Industry size and structure
- Competition and market shares
ANALYST CREDENTIALS
The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm of 43rd Parallel, LLC, is the author of the previous edition of this report. He is also the author of several other BCC Research studies related to the subject of this report, including HLC016D − Microelectronic Medical Implants: Products, Technologies and Opportunities; HLC038C − Patient Monitoring; HLC054B − Home Medical Equipment: Technologies and Global Markets; HLC045A − Prosthetics, Orthotics, and Cosmetic Enhancement Products; HLC014D − Telemedicine: Opportunities for Medical and Electronic Providers; HL048C − Healthcare Information Technology; HLC066A − Medical Automation Technologies, Products and Markets; and HLC070A − Preventive Healthcare Technologies, Products and Market.
Report Highlights
- The U.S. market for assistive technology is expected to be worth $38.2 billion in 2008, up from $36.4 billion in 2007. This should increase to $49.3 billion in 2013, a compound annual growth rate (CAGR) of 5.3%.
- The vision and reading aids segment dominates the market, generating $24.9 billion in 2007 and an estimated $26.1 billion in 2008 and $33.3 billion in 2013, a CAGR of 5.0%.
- The communication aids segment is worth $4.4 billion in 2007. This should increase slightly in 2008 and reach $5.4 billion in 2013, for a CAGR of 4.0%.
Report Highlights
-
The U.S. market for assistive technologies is projected to rise from $30.7 billion in 2005 to $39.4 billion in 2010, an AAGR (average annual growth rate) of 5.2%.
-
The market excluding eyeglasses and contacts is estimated at $8.7 billion and rising to $11.3 billion in 2010, an AAGR of 5.4%.
-
The largest market segments after vision and reading aids are daily living aids, mobility aids (expected to drop from 7.2% of the market to 5.7% in 2010) and communication aids.
-
Access aids appear poised to increase their market share from 2.9% in 2004 to 4.3% in 2010.
Related Reports
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
Healthcare Information Technology
BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010. The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.
Telemedicine: Opportunities for Medical and Electronic Providers
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, at a compound annual growth rate (CAGR) of 18.6% over the next 5 years.
Assistive Devices for Special Needs: Technologies and Global Markets
The global market for assistive devices for special needs reached $10.8 billion in 2010. This market is projected to increase at a 4.3% compound annual growth rate (CAGR) to reach more than $13 billion by 2015.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More